Aktis Oncology, Inc. AKTS
16.62 USD +0.34 (+2.09%)
At closeNov 13, 2026, 4:00 PM EST
16.62 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
15.76 Day range 16.73
14.59 52-week range 32.23
- YTD
- -25.80%
- 1 year
- -25.80%
News
benzinga.com Aktis Oncology Q3 EPS $(0.54) Misses $(0.48) Estimate, Sales $3.905M Miss $4.016M Estimate Aktis Oncology (NASDAQ:AKTS) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.48) by 12.5 percent. This is a 97.18 percent increase over losses of…
globenewswire.com Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress Initiated the Company's third Phase 1b clinical trial, BActinium-2, broadening the evaluation of AKY-2519 to lung cancer and other B7-H3 expressing tumors Started first backfill cohorts in the…
zacks.com Does Aktis (AKTS) Have the Potential to Rally 105.62% as Wall Street Analysts Expect? The mean of analysts' price targets for Aktis (AKTS) points to a 105.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts…
benzinga.com Wedbush Reiterates Outperform on Aktis Oncology, Maintains $35 Price Target Wedbush analyst David Nierengarten reiterates Aktis Oncology (NASDAQ:AKTS) with a Outperform and maintains $35 price target.- benzinga.com Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519 Phase 1b BActinium-2 clinical trial is evaluating AKY-2519 in patients with non-small cell lung cancer (NSCLC) and other B7-H3 expressing tumorsEnrollment is ongoing in the Phase 1b BActinium-1…
- benzinga.com Oppenheimer Initiates Coverage On Aktis Oncology with Outperform Rating, Announces Price Target of $40 Oppenheimer analyst Jeff Jones initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Outperform rating and announces Price Target of $40.
benzinga.com Wedbush Initiates Coverage On Aktis Oncology with Outperform Rating, Announces Price Target of $35 Wedbush analyst David Nierengarten initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Outperform rating and announces Price Target of $35.
benzinga.com BMO Capital Initiates Coverage On Aktis Oncology with Outperform Rating, Announces Price Target of $37 BMO Capital analyst David Lebowitz initiates coverage on Aktis Oncology (NASDAQ:AKTS) with a Outperform rating and announces Price Target of $37.
benzinga.com Micron and 15 Other Stocks To Play The AI Buildout Race: They Are Still 20% Below Highs Bank of America screened its AI baskets for Buy-rated stocks down over 20% from highs. Micron carries the widest gap to target.
benzinga.com Aktis Oncology Q2 EPS $(0.44) Misses $(0.43) Estimate, Sales $3.384M Beat $2.000M Estimate Aktis Oncology (NASDAQ:AKTS) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 98.03 percent increase over losses of…- benzinga.com JP Morgan Maintains Overweight on Aktis Oncology, Raises Price Target to $33 JP Morgan analyst Jessica Fye maintains Aktis Oncology (NASDAQ:AKTS) with a Overweight and raises the price target from $30 to $33.
benzinga.com DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday US stocks were mixed, Nasdaq fell 1%. DigitalOcean shares rose after strong revenue growth and earnings guidance. Other big gainers include CRNX, MAAS, and AGIO.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-market session. Crinetics Pharmaceuticals (NASDAQ:CRNX) stock moved upwards by 99.85% to $84.0. The…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's regular session. The market value of their outstanding shares is at $4.8 million. Seer (NASDAQ:SEER)…
benzinga.com This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrades, visit analyst ratings page. Consider buying AKTS stock? Analysts weigh in.
benzinga.com Rezolve AI, Bakkt, Seagate And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and other stocks such as ALOY and FWRD also rose.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views.
benzinga.com This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Top analysts change outlook on top names. See all analyst rating changes on Benzinga's analyst ratings page. Consider AKTS stock based on analyst views.
benzinga.com This GCI Liberty Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - benzinga.com Crude Oil Down 1%; Webuy Global Shares Spike Higher
- benzinga.com Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- benzinga.com 12 Information Technology Stocks Moving In Friday's After-Market Session
benzinga.com 12 Information Technology Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com 12 Information Technology Stocks Moving In Tuesday's Intraday Session - benzinga.com Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- benzinga.com US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
- benzinga.com Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
benzinga.com Earnings Scheduled For February 13, 2024 Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
benzinga.com 12 Information Technology Stocks Moving In Thursday's Intraday Session - benzinga.com Earnings Scheduled For November 13, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 225 companies set new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 179 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 128 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 155 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 188 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 103 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For May 8, 2023 Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
- benzinga.com Earnings Scheduled For February 7, 2023 Companies Reporting Before The Bell • BP (NYSE:BP) is likely to report quarterly earnings at $1.67 per share on revenue of $53.79 billion.
- benzinga.com Earnings Scheduled For November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 446 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 517 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 528 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 930 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 361 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.
- benzinga.com 12 Information Technology Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 215 companies set new 52-week lows.